Market Overview

Sarepta Therapeutics, Inc. (NASDAQ: SRPT)

143.20 -0.80 (-0.56%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/15/20CitigroupMaintainsBuy190.0
8/31/20HC Wainwright & Co.MaintainsBuy221.0
8/25/20Raymond JamesInitiates Coverage OnOutperform200.0
8/21/20B of A SecuritiesMaintainsBuy189.0
8/20/20Credit SuisseDowngradesNeutral167.0
8/10/20Morgan StanleyMaintainsOverweight182.0
4/15/20Morgan StanleyMaintainsOverweight172.0
3/31/20MizuhoInitiates Coverage OnBuy183.0
2/28/20JP MorganMaintainsOverweight160.0
2/27/20Cantor FitzgeraldReiteratesOverweight217.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter